FMC Corporation: Recent Analyst Adjustments and Market Context

FMC Corporation, a chemical‑materials company listed on the New York Stock Exchange, reported a closing share price of $14.76 on 5 February 2026. The company’s market capitalisation stands at $1.84 billion and its price‑to‑earnings ratio is ‑0.97, indicating that the firm is trading below earnings expectations.

Analyst‑Set Price Targets

  • Bank of America (BofA) – The brokerage lowered its price target for FMC from $17.00 to $16.00 while maintaining a neutral rating.
  • Morgan Stanley – The investment bank reduced its target from $17.00 to $15.50 in a research report issued on 8 February 2026.
  • RBC Capital – An analyst note on 6 February 2026 reported a lower target for FMC, though the exact figure was not disclosed.
  • Wells Fargo – On the same day, the brokerage maintained its rating for FMC but lowered its price target; the new target was not specified in the source material.

These successive downward revisions reflect a consensus among major research houses that FMC’s valuation may need adjustment in light of recent operational or financial developments.

Market Performance

  • The company’s 52‑week high was $44.78 (6 June 2025) and the 52‑week low was $12.17 (19 November 2025).
  • The current share price of $14.76 lies closer to the 52‑week low, suggesting a potential upside if the market sentiment improves.

Industry Outlook

Recent press releases from market‑overview agencies highlight growth expectations in the oilseed crop protection and crop bactericides sectors, where FMC is listed among key players.

  • The United States Oilseed Crop Protection Chemicals Market is projected to grow at a 3.9 % CAGR through 2031, with the Asia‑Pacific region leading the share.
  • The Crop Bactericides Market is forecast to reach $13.32 billion by 2031, again with 39 % of the share attributed to the Asia‑Pacific region.

FMC’s inclusion among the named competitors—Bayer, ADAMA, Syngenta, Nufarm, and UPL in the oilseed market; and BASF, Syngenta, Nufarm, Adama, Nippon Soda, American Vanguard, and Biostadt in the bactericides market—underscores its active role in these expanding segments.

Summary

FMC Corporation is currently trading near its 52‑week low, with a negative price‑to‑earnings ratio that suggests undervaluation relative to earnings. Major research firms have lowered their price targets in early February 2026, reflecting cautious expectations. However, the broader crop protection and bactericides markets are forecast to grow, offering potential upside for FMC if the company can leverage its position within these expanding sectors.